Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIP Infusion in Episodic Migraine Patients Without Aura
NCT04260035Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- May 2020
- Primary completion
- Sep 2020
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial in migraine comparing Vasoactive Intestinal Polypeptide (VIP) with Sterile, isotonic, non-active saline (Placebo) (2 arms). Primary endpoint: Occurrence of migraine-like attacks. Started May 2020; status: completed.
02
Drugs
vasoactive intestinal peptide
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04260035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04260035.